Physician profile
Hope E Uronis
NPI 1982729331
$34,757.12
in general payments reported to CMS, 2019-2025
10 companies · $4,948 in 2025
The $4,948 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,718 · 2022: $9,577 · 2023: $12K · 2024: $4,509 · 2025: $4,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,750 · Travel and Lodging: $976 · Food and Beverage: $416 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,252.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,750.00 |
| Travel and Lodging | $975.93 |
| Food and Beverage | $416.14 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Uk Limited | $16,724.65 | 2021-2025 | Imfinzi |
| Merck Sharp & Dohme LLC | $9,780.53 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $6,490.45 | 2021-2025 | |
| Daiichi Sankyo INC. | $1,440.00 | 2025 | Enhertu |
| Caris Mpi, INC. | $130.28 | 2025 | Mi Cancer Seek |
| Intera Oncology, INC | $122.72 | 2023 | Intera 3000 Implantable Pump |
| Astrazeneca Pharmaceuticals Lp | $68.49 | 2025 | Imfinzi |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hope Uronis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.